Filter
1736
Filtered Results: 1736
Text search:
D.
Yu
Featured
Recommendations
146
New Publications
288
Language
Document type
No document type
810
Studies & Reports
373
Guidelines
327
Manuals
105
Strategic & Response Plan
40
Training Material
32
Fact sheets
31
Infographics
7
Situation Updates
5
Resource Platforms
4
Brochures
2
Countries / Regions
Global
86
Indonesia
80
Latin America and the Carribbean
49
Western and Central Europe
44
India
44
Russia
42
Brazil
37
Myanmar / Burma
30
Germany
25
Ukraine
24
Kenya
23
Peru
22
Rwanda
20
Colombia
19
Argentina
19
Eastern Europe
18
South Africa
17
Tanzania
16
Bolivia
16
Ethiopia
14
Syria
13
Nigeria
13
Zimbabwe
13
Mozambique
13
Africa
13
Asia
13
Congo, Democratic Republic of
13
Uganda
13
Middle East and North Africa
12
Paraguay
12
Spain
12
Vietnam
12
Ghana
11
Sierra Leone
11
Cambodia
11
Zambia
11
Philippines
10
Eastern Europe and Central Asia
10
Ecuador
10
Senegal
9
Malawi
9
Venezuela
9
Bangladesh
9
Liberia
9
Nepal
8
Chile
8
Burkina Faso
8
South–East Asia Region
8
China
7
Cameroon
7
Angola
7
South Sudan
7
El Salvador
6
Laos
6
Lesotho
5
West and Central Africa
5
Yemen
5
Guinea
4
Western Pacific Region
4
France
4
Portugal
4
East and Southern Africa
4
Côte d’Ivoire / Ivory Coast
4
Haiti
3
Guinea-Bissau
3
Honduras
3
Mali
3
Madagascar
3
Eswatini/ Swaziland
3
North Macedonia
2
Tajikistan
2
Thailand
2
Mexico
2
Turkey
2
Benin
2
Albania
2
Canada
2
Kyrgyzstan
2
Niger
2
Burundi
2
Jordan
2
North America
2
United Kingdom
2
Belarus
2
Bosnia and Herzegovina
2
Nicaragua
2
Sudan
2
Chad
2
Somalia
2
Pakistan
2
Guatemala
2
Switzerland
1
Timor Leste/ East Timor
1
Kazakhstan
1
Singapore
1
Estonia
1
Congo-Brazzaville
1
Afghanistan
1
Malaysia
1
Austria
1
Mongolia
1
Italy
1
USA
1
Dominican Republic
1
Uruguay
1
Mauritius
1
Israel
1
Latvia
1
Lebanon
1
Moldova
1
Sri Lanka
1
Greece
1
Botswana
1
Iraq
1
Cuba
1
Authors & Publishers
Publication Years
Category
Countries
595
Clinical Guidelines
145
Public Health
106
Women & Child Health
83
Key Resources
41
Capacity Building
20
Pharmacy & Technologies
14
Toolboxes
COVID-19
295
Mental Health
240
TB
123
Planetary Health
94
HIV
86
Disability
55
NCDs
48
Caregiver
43
NTDs
42
Rapid Response
35
AMR
35
Refugee
34
Ebola
29
Global Health Education
29
Pharmacy
28
Conflict
26
Natural Hazards
20
Zika
13
Polio
10
Health Financing Toolbox
9
Specific Hazards
8
Cholera
6
Social Ethics
5
Health Financing
1
Cystic echinococcosis (CE) is a well-known neglected parasitic disease. However, evidence supporting the four current treatment modalities is inadequate, and treatment options remain controversial. The aim of this work is to analyse the available data to answer clinical questions regarding medical t...
This publication describes the first WHO public-benefit Target Product Profiles (TPPs) for snakebite antivenoms. It focuses on antivenoms for treatment of snakebite envenoming in sub-Saharan Africa. Four TPPs are described in the document:
Broad spectrum Pan-African polyvalent antivenoms: products ...
A System of Health Accounts 2011: Revised Edition provides an updated and systematic description of the financial flows related to the consumption of health care goods and services. As demands for information increase and more countries implement and institutionalise health accounts according to the...
The 2018 global health financing report presents health spending data for all WHO Member States between 2000 and 2016 based on the SHA 2011 methodology. It shows a transformation trajectory for the global spending on health, with increasing domestic public funding and declining external financing. T...
The UK government hosted the Global Vaccine Summit on June 4, 2020 under the patronage of the Rt. Hon. Boris Johnson, Prime Minister of the United Kingdom of Great Britain and Northern Ireland. The meeting was held by videoconference in light of the ongoing COVID-19 pandemic. 2. The Summit brought...
Little is known about foreign aid provided by private donors. This paper contributes to closing this research gap by comparing the allocation of private humanitarian aid to that of official humanitarian aid awarded to 140 recipient countries over the 2000-2016 period. We construct a new database tha...
Oral health is defined as the absence of disease and a status that ensures optimal functioning of the mouth and its tissues in a manner preserving the highest level of function and self-esteem. Oral health enables an individual to eat, speak and socialise having no active disease, discomfort or disc...
The Advancing Climate-Resilient Education Technical Guidance builds on the USAID 2022–2030 Climate Strategy and the 2018 USAID Education Policy to support USAID Missions and partners who seek to integrate climate action and awareness into education programs and are committed to achieving climate-r...
Developmental disabilities are common. Yet, children with developmental disabilities have been neglected in health systems planning and policy provisions for health and continue to experience stigmatization, institutionalization, barriers to access health care and inequalities in health and educatio...
Trustworthy, evidence-based health guidelines form the basis of national policies affecting both patients and health-care workers. Emphasizing the link between robust evidence and people’s trust in their health systems, Dr Hans Henri P. Kluge, WHO Regional Director for Europe said at the launch ev...
In In recent years, China has increased its international engagement in health. Nonetheless, the lack
of data on contributions has limited efforts to examine contributions from China. Existing estimates that track
development assistance for health (DAH) from China have relied primarily on one data...
People affected by impairments and disabilities associated with TB are even more likely to belong to marginalized segments of society and are more likely to have their human rights unprotected. The challenges faced by people affected by TB include the consequences of impairment and disability associ...
Background: Cardiovascular disease (CVD), mainly heart attack and stroke, is the
leading cause of premature mortality in low and middle income countries (LMICs).
Identifying and managing individuals at high risk of CVD is an important strategy to prevent and control CVD, in addition to multisector...
Many features of the environment have been found to exert an important influence on cardiovascular disease (CVD) risk, progression, and severity. Changes in the environment due to migration to different geographic locations, modifications in lifestyle choices, and shifts in social policies and cultu...
The Coronavirus Disease 2019 (COVID-19) has had a continuous and robust impact on world health. The resulting COVID-19 pandemic has had a devastating physical, mental and fiscal impact on the millions of people living with noncommunicable diseases (NCDs), as they have a higher risk of severe illness...
Prevention of stroke and transient ischemic attack includes both conventional approaches to vascular risk factor management (blood pressure lowering, cholesterol reduction with statins, smoking cessation and antiplatelet therapy)
and more specific interventions, such as carotid revascularization or...
Vaccines are powerful weapons in the fight against pandemic viruses as shown by responses to both the 2009 H1N1 influenza and the COVID-19 pandemics. However, planning for accessing, allocating and deploying vaccines in a pandemic situation is a complex endeavour, beset with multiple challenges at a...
Cardiovascular diseases (CVDs) have collectively remained the leading causes of death worldwide and substantially contribute to loss of health and excess health system costs. The Global Burden of Diseases, Injuries, and Risk Factors (GBD) Study has tracked trends in death and disability since 1990 a...
While epidemiological data for type 1 diabetes (T1D) in low/middle-income countries, and particularly low-income countries (LICs) including Liberia is lacking, prevalence in LICs is thought to be increasing. T1D care in LICs is often impacted by challenges in diagnosis and management. These challeng...
